---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-11T08:50:24.802936'
end_time: '2026-02-11T08:58:00.787697'
duration_seconds: 455.99
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: SCO2
  gene_symbol: SCO2
  uniprot_accession: O43819
  protein_description: 'RecName: Full=Cytochrome c oxidase assembly factor SCO2 {ECO:0000305};
    Flags: Precursor;'
  gene_info: Name=SCO2;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the SCO1/2 family. .
  protein_domains: SCO1/SenC. (IPR003782); Synth_of_cyt-c-oxidase_Sco1/2. (IPR017276);
    Thioredoxin-like_sf. (IPR036249); Thioredoxin_domain. (IPR013766); SCO1-SenC (PF02630)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 21
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O43819
- **Protein Description:** RecName: Full=Cytochrome c oxidase assembly factor SCO2 {ECO:0000305}; Flags: Precursor;
- **Gene Information:** Name=SCO2;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the SCO1/2 family. .
- **Key Domains:** SCO1/SenC. (IPR003782); Synth_of_cyt-c-oxidase_Sco1/2. (IPR017276); Thioredoxin-like_sf. (IPR036249); Thioredoxin_domain. (IPR013766); SCO1-SenC (PF02630)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "SCO2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'SCO2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **SCO2** (gene ID: SCO2, UniProt: O43819) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O43819
- **Protein Description:** RecName: Full=Cytochrome c oxidase assembly factor SCO2 {ECO:0000305}; Flags: Precursor;
- **Gene Information:** Name=SCO2;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the SCO1/2 family. .
- **Key Domains:** SCO1/SenC. (IPR003782); Synth_of_cyt-c-oxidase_Sco1/2. (IPR017276); Thioredoxin-like_sf. (IPR036249); Thioredoxin_domain. (IPR013766); SCO1-SenC (PF02630)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "SCO2" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'SCO2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **SCO2** (gene ID: SCO2, UniProt: O43819) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human SCO2 (UniProt O43819)

Plan verification and identity safeguards
- Gene/protein identity: The target is human SCO2, UniProt O43819, annotated as a cytochrome c oxidase (complex IV) assembly factor belonging to the SCO1/2 family with thioredoxin-like features. Literature consistently places human SCO proteins in the cytochrome c oxidase copper delivery pathway and distinguishes SCO2 from SCO1 by cooperative, nonredundant roles in COX2 CuA-site biogenesis (guaragnella2024morethanjust pages 13-14, swaminathan2022theroleof pages 1-2).
- Organism and family/domains: Human, SCO1/2 family; SCO proteins present a thioredoxin-like fold with a conserved Cys–x–x–x–Cys motif implicated in redox and copper-binding chemistry during CuA-site assembly (swaminathan2022theroleof pages 9-9, swaminathan2022theroleof pages 6-7).

Key concepts and definitions
- Primary biological role: SCO2 is an inner-mitochondrial-membrane protein with its functional domain exposed to the intermembrane space (IMS). It participates in the dedicated CuA-site assembly pathway of COX2 (the mtDNA-encoded subunit II of complex IV), enabling insertion of the binuclear CuA center required for electron transfer from cytochrome c to the catalytic core (nietopanqueva2024identificationoffactors pages 1-2, swaminathan2022theroleof pages 9-9).
- Mechanistic activities and substrates: SCO2 functions in the copper-delivery relay together with SCO1 and COA6, acting primarily through thiol–disulfide redox chemistry on cysteine pairs required to coordinate Cu in COX2 and SCO proteins. COA6 maintains SCO1, SCO2, and COX2 cysteines in the reduced state; reported redox potentials (COA6 ≈ −330 to −349 mV; SCO2 < −300 mV; SCO1 ≈ −280 mV) support thermodynamically favorable electron flow from COA6 to SCO proteins and COX2, enabling Cu(I) binding and CuA assembly (swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9).
- Interactions and pathway topology: Evidence supports physical/functional interactions among SCO2, SCO1, COA6, and COX2 during CuA assembly. Reviews highlight an SCO1–SCO2–COA6 relay that forms ternary or transient assemblies with apo-COX2, with each SCO protein contributing to delivery of copper equivalents to form the CuA center (guaragnella2024morethanjust pages 14-16, swaminathan2022theroleof pages 6-7).

Recent developments and latest research (2023–2024 priority)
- Human genetic and disease synthesis (2023): A state-of-the-art review summarized SCO2 as a key COX assembly factor within the mitochondrial copper-delivery network. Clinically, SCO2 pathogenic variants commonly cause severe, early-onset complex IV deficiency with cardiomyopathy and neuromuscular involvement, and E140K (Glu140Lys) is repeatedly the most common allele reported in patients, often as a component of compound heterozygosity (Trends in Endocrinology & Metabolism, 2023; https://doi.org/10.1016/j.tem.2022.11.001) (garza2023mitochondrialcopperin pages 13-15).
- Model system insights (2024): Yeast/human comparative reviews published in 2024 reinforce cooperative but distinct roles for SCO1 and SCO2 in CuA assembly and emphasize COA6’s redox role in maintaining SCO proteins competent for copper transfer to COX2. These sources compile variant evidence (including E140K) and functional genetics that anchor SCO2 to the IMS CuA biogenesis module (Int J Mol Sci, 2024; https://doi.org/10.3390/ijms25073814) (guaragnella2024morethanjust pages 13-14, guaragnella2024morethanjust pages 14-16, guaragnella2024morethanjust pages 24-25).
- Assembly-pathway context (2024): A 2024 Genetics study of COX2 biogenesis in yeast highlights the Sco1/Sco2/Coa6/Cox12 copper-relay system for CuA-site assembly in the IMS following COX2 membrane insertion and processing, situating SCO2 squarely in a conserved IMS relay that metallates the COX2 C-terminal domain (Genetics, 2024; https://doi.org/10.1093/genetics/iyae058) (nietopanqueva2024identificationoffactors pages 1-2).

Current applications and real-world implementations
- Experimental systems: Yeast, mammalian cell models, and biochemical redox assays are the primary systems for dissecting SCO2 function and variant pathogenicity. Synthetic-lethal genetics and protein–protein interaction studies have established interdependence of SCO2 with COA6 and SCO1, and in vitro redox assays demonstrate COA6-mediated reduction of SCO2 and COX2 disulfides to permit copper binding (swaminathan2022ayeastsuppressor pages 12-12, swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9).
- Clinical and diagnostic context: While not pointing to SCO2-targeted therapeutics, the contemporary literature consolidates SCO2 within diagnostic gene panels for mitochondrial complex IV deficiency and informs variant interpretation (e.g., E140K as a recurrent disease allele). The assembled clinical evidence emphasizes severe early-onset phenotypes and rapidly progressive courses, guiding genetic counseling and supportive management (garza2023mitochondrialcopperin pages 13-15).

Expert opinions and analysis from authoritative sources
- Consensus on function: Authoritative reviews converge on SCO2’s role as an IMS-exposed assembly factor acting in the CuA module. The weight of evidence favors a redox-chaperone function that prepares COX2 and SCO cysteines for copper coordination rather than direct copper donation per se; COA6 appears to be the principal disulfide reductase in the module, sustaining SCO2 in its active reduced state (swaminathan2022theroleof pages 9-9, swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9).
- Interactome positioning: Syntheses emphasize that SCO2, with SCO1 and COA6, forms the core of the COX2 CuA metallation machinery. This module acts after COX2 transmembrane insertion and leader processing and before incorporation into higher-order assembly intermediates, aligning SCO2’s role with a discrete, redox-sensitive step in complex IV maturation (nietopanqueva2024identificationoffactors pages 1-2, guaragnella2024morethanjust pages 14-16).

Relevant statistics and data from recent studies
- Clinical outcomes and phenotypes: Aggregated patient summaries indicate SCO2 disease often manifests as hypertrophic cardiomyopathy, hepatomegaly, muscle hypotonia, neuropathy, and elevated lactate; many compound-heterozygous individuals carrying E140K succumb within six months. Tissue biochemistry shows markedly decreased complex IV (COX) activity and reduced complex IV–containing supercomplexes in muscle/liver (Trends Endocrinol Metab, 2023; https://doi.org/10.1016/j.tem.2022.11.001) (garza2023mitochondrialcopperin pages 13-15).
- Mechanistic energetics: Reported redox potentials provide quantitative support for the directionality of electron transfer within the CuA assembly module (COA6 ≈ −330 to −349 mV vs. SCO2 < −300 mV and SCO1 ≈ −280 mV), establishing a thermodynamic basis for COA6-driven reduction of SCO targets (Biomolecules, 2022; https://doi.org/10.3390/biom12010125) (swaminathan2022theroleof pages 6-7).

Subcellular localization and structural inferences
- Localization: SCO-family proteins are integral to the inner mitochondrial membrane with IMS-facing domains, consistent with the location of COX2’s CuA-binding C-terminal domain. Yeast work places the CuA assembly relay in the IMS after COX2 processing and export of its C-terminus, and human-focused reviews describe analogous IMS exposure and membrane anchoring for SCO proteins (Genetics, 2024; https://doi.org/10.1093/genetics/iyae058; Int J Mol Sci, 2024; https://doi.org/10.3390/ijms25073814) (nietopanqueva2024identificationoffactors pages 1-2, guaragnella2024morethanjust pages 14-16).
- Domain/family: SCO2 is a member of the conserved SCO1/2 family with a thioredoxin-like fold and the hallmark Cys–x–x–x–Cys motif central to redox and copper-binding chemistry in CuA assembly (Biomolecules, 2022; https://doi.org/10.3390/biom12010125) (swaminathan2022theroleof pages 9-9, swaminathan2022theroleof pages 6-7).

Pathway placement and sequence of events
- After COX2 membrane integration and proteolytic processing, the IMS-exposed C-terminus engages the SCO/COA6 copper-relay. COA6 reduces disulfides in SCO2 (and SCO1/COX2), enabling Cu(I) binding and transfer steps that form the binuclear CuA site on COX2. SCO2 (with SCO1) likely contacts apo-COX2 in transient or ternary assemblies to deliver copper equivalents necessary for CuA maturation, culminating in incorporation of COX2 into complex IV assembly intermediates (nietopanqueva2024identificationoffactors pages 1-2, swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9, guaragnella2024morethanjust pages 14-16).

Disease associations and founder variants
- SCO2 pathogenic variants produce mitochondrial complex IV deficiency with infantile cardio‑encephalomyopathy and neuromuscular features. The recurrent E140K missense allele is the most frequently reported variant in patient cohorts and is commonly observed in compound-heterozygous genotypes associated with rapid clinical decline and death in infancy (Trends Endocrinol Metab, 2023; https://doi.org/10.1016/j.tem.2022.11.001; Int J Mol Sci, 2024; https://doi.org/10.3390/ijms25073814) (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 14-16).

Limitations and open questions
- Precise stoichiometry and sequence of copper hand-off among COA6, SCO1, SCO2, and COX2 remain under active investigation, as do the direct electron donors to COA6 in vivo and any condition-specific modulation of the IMS redox state during CuA assembly (swaminathan2022theroleof pages 7-9, swaminathan2022theroleof pages 9-9).

Embedded summary table
| Category | Finding | Source |
|---|---|---|
| Identity | UniProt O43819: Cytochrome c oxidase assembly factor SCO2; member of the SCO1/2 family with thioredoxin-like features/annotations. | Guaragnella et al., Int J Mol Sci 2024, DOI: 10.3390/ijms25073814 (2024); Swaminathan & Gohil, Biomolecules 2022, DOI: 10.3390/biom12010125 (2022) (guaragnella2024morethanjust pages 13-14, swaminathan2022theroleof pages 9-9) |
| Localization | Mitochondrial inner membrane protein with the bulk of the mature domain in the intermembrane space (IMS); encoded as a precursor with mitochondrial targeting/import. | Nieto-Panqueva et al., Genetics 2024, DOI: 10.1093/genetics/iyae058 (2024); Guaragnella et al., Int J Mol Sci 2024 (nietopanqueva2024identificationoffactors pages 1-2, guaragnella2024morethanjust pages 14-16) |
| Primary function | Participates in assembly/metalation of the CuA dinuclear copper site in COX2 (Complex IV) via copper delivery and redox (thiol–disulfide) activity enabling Cu binding. | Swaminathan & Gohil, Biomolecules 2022, DOI: 10.3390/biom12010125 (2022); Garza et al., Trends Endocrinol Metab 2023, DOI: 10.1016/j.tem.2022.11.001 (2023) (swaminathan2022theroleof pages 9-9, garza2023mitochondrialcopperin pages 13-15) |
| Interactors | Forms functional/physical interactions with SCO1, COA6, and apo-COX2; reported as part of ternary/relay complexes in CuA assembly. | Swaminathan & Gohil, Biomolecules 2022; Guaragnella et al., Int J Mol Sci 2024 (swaminathan2022theroleof pages 6-7, guaragnella2024morethanjust pages 14-16) |
| Mechanism | Conserved Cys‑x‑x‑x‑Cys motif and thioredoxin-like/redox behaviour; acts in disulfide‑reduction steps that permit Cu binding. COA6 reduces SCO1/SCO2/COX2 cysteines (reported COA6 reduction potential ≈ -330 to -349 mV vs. SCO2 < -300 mV), making COA6→SCO reduction thermodynamically favorable. | Swaminathan & Gohil, Biomolecules 2022, DOI: 10.3390/biom12010125 (2022) (swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9) |
| Disease | Pathogenic SCO2 variants cause early-onset Complex IV deficiency: infantile cardio‑encephalomyopathy, hypertrophic cardiomyopathy, hypotonia, neuropathy, elevated lactate, and decreased COX (Complex IV) activity in tissues. | Garza et al., Trends Endocrinol Metab 2023, DOI: 10.1016/j.tem.2022.11.001 (2023); Guaragnella et al., Int J Mol Sci 2024 (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 14-16) |
| Founder variant | E140K (Glu140Lys) is the most commonly reported SCO2 patient variant in clinical series and is frequently seen in compound‑heterozygous genotypes associated with severe infantile COX deficiency. | Garza et al., Trends Endocrinol Metab 2023, DOI: 10.1016/j.tem.2022.11.001 (2023); Guaragnella et al., Int J Mol Sci 2024 (garza2023mitochondrialcopperin pages 13-15, guaragnella2024morethanjust pages 14-16) |
| Applications | Yeast genetics and human cell models are routinely used to study SCO2 function, model pathogenic variants, and test genetic/functional complementation; these systems underpin mechanistic and variant‑pathogenicity studies. | Guaragnella et al., Int J Mol Sci 2024, DOI: 10.3390/ijms25073814 (2024); Swaminathan et al., Genetics 2022 (guaragnella2024morethanjust pages 13-14, swaminathan2022ayeastsuppressor pages 12-12) |
| Recent updates (2023–2024) | Recent reviews and experimental work (2023–2024) have emphasized COA6's role as a disulfide reductase in the CuA pathway, reinforced cooperative yet distinct roles for SCO1 and SCO2, and continued use of yeast/human models to dissect assembly steps. | Garza et al., Trends Endocrinol Metab 2023; Nieto-Panqueva et al., Genetics 2024; Guaragnella et al., Int J Mol Sci 2024 (garza2023mitochondrialcopperin pages 13-15, nietopanqueva2024identificationoffactors pages 1-2, guaragnella2024morethanjust pages 14-16) |


*Table: Compact summary table of validated, literature‑supported facts about human SCO2 (UniProt O43819): identity, localization, function, interactions, mechanism, disease links, and recent 2023–2024 updates, with primary sources cited for each entry.*

Conclusion
Human SCO2 (UniProt O43819) is a mitochondrial inner-membrane assembly factor with an IMS-exposed, thioredoxin-like domain and a conserved Cys–x–x–x–Cys motif. It functions within a redox-sensitive copper-relay module—together with SCO1 and COA6—that builds the COX2 CuA site, a prerequisite for complex IV function. Disruption of SCO2 leads to severe infantile complex IV deficiency, typically presenting with cardiomyopathy and neuromuscular disease; the E140K variant is the most recurrently reported allele in patient cohorts. Recent 2023–2024 work consolidates SCO2’s placement in the IMS CuA module and emphasizes COA6-mediated redox control as central to enabling SCO2 function in copper delivery and COX2 maturation (garza2023mitochondrialcopperin pages 13-15, nietopanqueva2024identificationoffactors pages 1-2, guaragnella2024morethanjust pages 14-16, swaminathan2022theroleof pages 6-7, swaminathan2022theroleof pages 7-9).

References

1. (guaragnella2024morethanjust pages 13-14): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations and is from a poor quality or predatory journal.

2. (swaminathan2022theroleof pages 1-2): Abhinav B. Swaminathan and Vishal M. Gohil. The role of coa6 in the mitochondrial copper delivery pathway to cytochrome c oxidase. Biomolecules, 12:125, Jan 2022. URL: https://doi.org/10.3390/biom12010125, doi:10.3390/biom12010125. This article has 53 citations and is from a poor quality or predatory journal.

3. (swaminathan2022theroleof pages 9-9): Abhinav B. Swaminathan and Vishal M. Gohil. The role of coa6 in the mitochondrial copper delivery pathway to cytochrome c oxidase. Biomolecules, 12:125, Jan 2022. URL: https://doi.org/10.3390/biom12010125, doi:10.3390/biom12010125. This article has 53 citations and is from a poor quality or predatory journal.

4. (swaminathan2022theroleof pages 6-7): Abhinav B. Swaminathan and Vishal M. Gohil. The role of coa6 in the mitochondrial copper delivery pathway to cytochrome c oxidase. Biomolecules, 12:125, Jan 2022. URL: https://doi.org/10.3390/biom12010125, doi:10.3390/biom12010125. This article has 53 citations and is from a poor quality or predatory journal.

5. (nietopanqueva2024identificationoffactors pages 1-2): Felipe Nieto-Panqueva, Miriam Vázquez-Acevedo, Patrice P Hamel, and Diego González-Halphen. Identification of factors limiting the allotopic production of the cox2 subunit of yeast cytochrome c oxidase. Genetics, Apr 2024. URL: https://doi.org/10.1093/genetics/iyae058, doi:10.1093/genetics/iyae058. This article has 2 citations and is from a domain leading peer-reviewed journal.

6. (swaminathan2022theroleof pages 7-9): Abhinav B. Swaminathan and Vishal M. Gohil. The role of coa6 in the mitochondrial copper delivery pathway to cytochrome c oxidase. Biomolecules, 12:125, Jan 2022. URL: https://doi.org/10.3390/biom12010125, doi:10.3390/biom12010125. This article has 53 citations and is from a poor quality or predatory journal.

7. (guaragnella2024morethanjust pages 14-16): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations and is from a poor quality or predatory journal.

8. (garza2023mitochondrialcopperin pages 13-15): Natalie M. Garza, Abhinav B. Swaminathan, Krishna P. Maremanda, Mohammad Zulkifli, and Vishal M. Gohil. Mitochondrial copper in human genetic disorders. Trends in Endocrinology &amp; Metabolism, 34:21-33, Jan 2023. URL: https://doi.org/10.1016/j.tem.2022.11.001, doi:10.1016/j.tem.2022.11.001. This article has 116 citations and is from a domain leading peer-reviewed journal.

9. (guaragnella2024morethanjust pages 24-25): Nicoletta Guaragnella, T. Cervelli, Bel é m Sampaio-Marques, Chenelle A. Caron-Godon, Emma Collington, Jessica L. Wolf, Genna Coletta, and D. M. Glerum. More than just bread and wine: using yeast to understand inherited cytochrome oxidase deficiencies in humans. International Journal of Molecular Sciences, 25:3814, Mar 2024. URL: https://doi.org/10.3390/ijms25073814, doi:10.3390/ijms25073814. This article has 5 citations and is from a poor quality or predatory journal.

10. (swaminathan2022ayeastsuppressor pages 12-12): Abhinav B Swaminathan, Shivatheja Soma, Alison C Vicary, Mohammad Zulkifli, Harman Kaur, and Vishal M Gohil. A yeast suppressor screen links coa4 to the mitochondrial copper delivery pathway for cytochrome c oxidase. Genetics, Jun 2022. URL: https://doi.org/10.1093/genetics/iyac090, doi:10.1093/genetics/iyac090. This article has 15 citations and is from a domain leading peer-reviewed journal.

## Citations

1. garza2023mitochondrialcopperin pages 13-15
2. nietopanqueva2024identificationoffactors pages 1-2
3. swaminathan2022theroleof pages 6-7
4. guaragnella2024morethanjust pages 13-14
5. swaminathan2022theroleof pages 1-2
6. swaminathan2022theroleof pages 9-9
7. swaminathan2022theroleof pages 7-9
8. guaragnella2024morethanjust pages 14-16
9. guaragnella2024morethanjust pages 24-25
10. swaminathan2022ayeastsuppressor pages 12-12
11. https://doi.org/10.1016/j.tem.2022.11.001
12. https://doi.org/10.3390/ijms25073814
13. https://doi.org/10.1093/genetics/iyae058
14. https://doi.org/10.3390/biom12010125
15. https://doi.org/10.1093/genetics/iyae058;
16. https://doi.org/10.1016/j.tem.2022.11.001;
17. https://doi.org/10.3390/ijms25073814,
18. https://doi.org/10.3390/biom12010125,
19. https://doi.org/10.1093/genetics/iyae058,
20. https://doi.org/10.1016/j.tem.2022.11.001,
21. https://doi.org/10.1093/genetics/iyac090,